ArticleOphthalmology and therapy2022

Results from a Prospective, Open-Label, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye Disease.

Melissa Toyos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.